David L Hooper

Address:

625 Colonial Dr, Portland, TX 78374

VIN:

1N6AD07U77C451031

Make:

NISSAN

Model:

FRONTIER

Year:

2007

US Patent:

7588749, Sep 15, 2009

Filed:

Mar 29, 2007

Appl. No.:

11/727978

Inventors:

David M. Hooper - Austin TX, US
Thomas Foster - Boulder CO, US
Noel Henson - Valley WA, US

Assignee:

Minimus Spine, Inc. - Austin TX

International Classification:

C01B 13/10
B01D 53/04

US Classification:

423581

Abstract:

Apparatus, method and system for delivering a sterile unit dose of ozone that may include concentrating oxygen from air, which can include pressurizing at least one zeolite chamber having at least one zeolite material where the at least one zeolite material selectively adsorbs a substantial amount of nitrogen and not a substantial amount of oxygen. An oxygen-ozone cell may be filled with substantially concentrated oxygen from the at least one zeolite chamber. The oxygen-ozone cell may then be sequestered. The oxygen-ozone cell may be removed and may be engaged with an ozone conversion unit. The ozone conversion unit may charge the substantially concentrated oxygen generating a predetermined concentration of ozone. The oxygen-ozone cell may be disengaged from the ozone conversion unit.

US Patent:

8057748, Nov 15, 2011

Filed:

Oct 24, 2007

Appl. No.:

11/976362

Inventors:

David M. Hooper - Austin TX, US
Thomas Foster - Boulder CO, US
Noel Henson - Valley WA, US

Assignee:

Minimus Spine, Inc. - Austin TX

International Classification:

B01J 19/08

US Classification:

42218607, 204176, 604 25, 96108, D24114

Abstract:

In accordance with at least one exemplary embodiment, a syringe, method and system for delivering a therapeutic amount of ozone are disclosed. An exemplary syringe can have a gas chamber and one or more electrodes. A portion of at least one electrode can be within the gas chamber. Alternatively, singularly or in conjunction, one or both electrodes can be attached to the outside of an exemplary syringe. One or more electrical contact points can be outside the gas chamber. Each electrical contact point can be connected to an electrode. Oxygen gas can provided within the gas chamber of the exemplary syringe. A medical ozone generator can be connected to the syringe via the electrical contact points. Corona discharge can be effectuated via the electrodes, which can result in an amount of ozone gas can being produced from the oxygen gas.

US Patent:

8241581, Aug 14, 2012

Filed:

Sep 27, 2006

Appl. No.:

11/527414

Inventors:

David M. Hooper - Austin TX, US
Thomas Allen Foster - Boulder CO, US

Assignee:

Minimus Spine, Inc. - Austin TX

International Classification:

C01B 13/11

US Classification:

42218607, 422186, 42218608

Abstract:

Apparatus, method and system for delivering sterile unit dose of ozone. System includes sterile vial containing oxygen and corona discharge assembly. Sterile vial is engaged to ozone conversion unit having high voltage transformer, ozone measurement mechanism, data input mechanism, and displayed read-out. When power is supplied to sterile vial containing corona discharge assembly, oxygen is converted to specified concentration of ozone. Sterile vial is disengaged from ozone conversion unit, drawing port is attached, and needle or similar extraction tool is used to withdrawal ozone for treatment.

US Patent:

8337768, Dec 25, 2012

Filed:

Oct 3, 2011

Appl. No.:

13/251433

Inventors:

David M. Hooper - Austin TX, US
Thomas Foster - Boulder CO, US
Noel Henson - Valley WA, US

International Classification:

B01J 19/08

US Classification:

42218607, 204176

Abstract:

In accordance with at least one exemplary embodiment, a syringe, method and system for delivering a therapeutic amount of ozone are disclosed. An exemplary syringe can have a gas chamber and one or more electrodes. A portion of at least one electrode can be within the gas chamber. Alternatively, singularly or in conjunction, one or both electrodes can be attached to the outside of an exemplary syringe. One or more electrical contact points can be outside the gas chamber. Each electrical contact point can be connected to an electrode. Oxygen gas can provided within the gas chamber of the exemplary syringe. A medical ozone generator can be connected to the syringe via the electrical contact points. Corona discharge can be effectuated via the electrodes, which can result in an amount of ozone gas can being produced from the oxygen gas.

US Patent:

8486342, Jul 16, 2013

Filed:

Nov 6, 2012

Appl. No.:

13/670123

Inventors:

David M. Hooper - Austin TX, US
Thomas Foster - Boulder CO, US
Noel Henson - Valley WA, US

Assignee:

Minimus Spine, Inc. - Austin TX

International Classification:

B01J 19/08

US Classification:

42218607, 204176, 604 25, 96108, D24114

Abstract:

In accordance with at least one exemplary embodiment, a syringe, method and system for delivering a therapeutic amount of ozone are disclosed. An exemplary syringe can have a gas chamber and one or more electrodes. A portion of at least one electrode can be within the gas chamber. Alternatively, singularly or in conjunction, one or both electrodes can be attached to the outside of an exemplary syringe. One or more electrical contact points can be outside the gas chamber. Each electrical contact point can be connected to an electrode. Oxygen gas can provided within the gas chamber of the exemplary syringe. A medical ozone generator can be connected to the syringe via the electrical contact points. Corona discharge can be effectuated via the electrodes, which can result in an amount of ozone gas can being produced from the oxygen gas.

US Patent:

8609033, Dec 17, 2013

Filed:

Dec 6, 2011

Appl. No.:

13/312333

Inventors:

David M Hooper - Austin TX, US
Robert T. Reichenbach - Pflugerville TX, US
Roland Schneider - Round Rock TX, US

Assignee:

Minimus Spine, Inc. - Austin TX

International Classification:

B01J 19/08

US Classification:

42218607, 204176, 604 25, D24114

Abstract:

In accordance with at least one exemplary embodiment, a syringe, method and system for delivering a therapeutic amount of ozone are disclosed. An exemplary syringe can have a gas chamber and one or more electrodes. A portion of at least one electrode can be within the gas chamber. Alternatively, singularly or in conjunction, one or both electrodes can be attached to the outside of an exemplary syringe. One or more electrical contact points can be outside the gas chamber. Each electrical contact point can be connected to an electrode. Oxygen gas can provided within the gas chamber of the exemplary syringe. A medical ozone generator can be connected to the syringe via the electrical contact points. Corona discharge can be effectuated via the electrodes, which can result in an amount of ozone gas can being produced from the oxygen gas.

US Patent:

20070118218, May 24, 2007

Filed:

Nov 22, 2005

Appl. No.:

11/287077

Inventors:

David Hooper - Austin TX, US

International Classification:

A61F 2/28

US Classification:

623014120

Abstract:

A method for repairing a facet joint of a human vertebra having a joint capsule surrounding the facet joint. In the method, a synthetic elastic material is introduced into the facet joint. The synthetic elastic material can be a solid, swellable polymer that expands when hydrated upon being placed in the facet joint. The invention includes the implant and the method of making the implant.

US Patent:

20080045949, Feb 21, 2008

Filed:

Jun 19, 2006

Appl. No.:

11/455401

Inventors:

Margaret Hunt - Cedar Park TX, US
David Hooper - Austin TX, US
Alain Meunier - Bordeaux, FR
James Jara-Almonte - Kenosha WI, US

International Classification:

A61B 17/58

US Classification:

606061000, 606076000, 606086000

Abstract:

The present invention describes methods for treating a degenerative intervertebral disc disorder comprising implanting a disc stabilization device into a subject and administering at least one therapeutic agent which promotes healing of the disc to the subject. The invention also includes methods of promoting healing of damaged or degenerated intervertebral discs comprising decreasing the load of the disc through a disc stabilization device and inhibiting the inflammatory process. Also described are hydrogels for use in combination with extradiscal stabilization devices, as intradiscal stabilization devices, as drug carriers, and as combinations thereof.